Home/Rare Diseases/Pheochromocytoma

Endocrine & Hormonal

Pheochromocytoma

Also called Chromaffin Cell Tumor, Paraganglioma (extra-adrenal)

Pheochromocytoma is a neuroendocrine tumor arising from chromaffin cells, most commonly in the adrenal medulla (90%), though extra-adrenal tumors (paragangliomas) occur in 10%. The tumor produces catecholamines (epinephrine and norepinephrine) that cause the characteristic symptoms.

View active trialsMatch me to a trial

About Pheochromocytoma

Pheochromocytoma is a neuroendocrine tumor arising from chromaffin cells, most commonly in the adrenal medulla (90%), though extra-adrenal tumors (paragangliomas) occur in 10%. The tumor produces catecholamines (epinephrine and norepinephrine) that cause the characteristic symptoms. Episodic catecholamine release causes sudden hypertensive attacks with severe headache, sweating, palpitations, and anxiety. Attacks can be triggered by abdominal pressure, exercise, micturition, foods containing tyramine, or occur spontaneously. The rule of 10s classically applied: 10% bilateral, 10% familial, 10% malignant, 10% extra-adrenal, 10% in children. However, newer genetic and imaging data suggest higher rates of hereditary disease. Sustained hypertension or episodic hypertension with normal blood pressure between attacks both occur. Untreated tumors increase risk of myocardial infarction, stroke, cardiomyopathy, and sudden cardiac death. Long-term catecholamine excess can cause irreversible complications. About 10% are malignant with metastatic potential, particularly SDH mutation-associated tumors. Genetic testing is recommended for all patients to identify hereditary syndromes.

Common Symptoms

  • Severe hypertension, often episodic or paroxysmal
  • Intense headaches during attacks
  • Profuse sweating
  • Palpitations and chest or abdominal pain
  • Tremor, anxiety, and sense of impending doom
  • Syncope (fainting) or hypertensive crisis with stroke risk

Who It Affects

Pheochromocytoma can develop at any age but is most common in the fourth and fifth decades of life. It affects males and females roughly equally. The disease occurs across all racial and ethnic groups. About 30-40% of cases are hereditary, associated with MEN2, NF1, VHL, or SDHA/B/C/D syndromes. Hereditary cases often present at younger ages and may be bilateral or extra-adrenal.

Getting Involved in Clinical Trials

Clinical trials for Pheochromocytoma focus on novel targeted therapies for malignant and hereditary forms, including SDH inhibitors and other molecular approaches. Surgery is the primary treatment for localized disease, with trials optimizing perioperative management. Chemotherapy, radiation therapy, and molecular targeted therapies are being refined for malignant disease. Patients should consult with an endocrinologist experienced in adrenal tumors for appropriate genetic testing and treatment planning.

Trusted Sources

Active Clinical Trials for Pheochromocytoma

Finding trials for Pheochromocytoma...

Related Endocrine & Hormonal Conditions

Endocrine & Hormonal

Addison Disease

Addison Disease is a rare endocrine disorder in which the adrenal glands fail to produce adequate cortisol and aldostero...

Endocrine & Hormonal

Acromegaly

Acromegaly is a rare hormonal disorder caused by excessive growth hormone production, typically from a pituitary adenoma...

Endocrine & Hormonal

Cushing Disease

Cushing Disease is a rare endocrine disorder caused by an ACTH-secreting pituitary adenoma that leads to excessive corti...